首页> 美国卫生研究院文献>Annals of Medicine and Surgery >Variability of the f-cell ratio after treatment of traumatic hemorrhagic shock
【2h】

Variability of the f-cell ratio after treatment of traumatic hemorrhagic shock

机译:外伤性休克治疗后f细胞比率的变异性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeMeasuring total blood volume (TBV) in critically ill patients, using isotope techniques to determine red cell volume (RBCV) and plasma volume (PV) is laborious. Recently, PV measurement using a single bolus dose of tracers has been validated, thus, allowing TBV calculation using large venous hematocrit (LVHCT). However, this technique relies on using a correlation factor, the f-cell ratio, to adjust for differences in LVHCT and total body hematocrit (TBHCT). The normal f-cell ratio is 0.9 but has never been studied in patients recovering from hemorrhagic shock (HS). This study assesses the f-cell ratio at different phases after HS to determine accuracy in calculating TBV.
机译:目的测量重症患者的总血容量(TBV),使用同位素技术确定红细胞容量(RBCV)和血浆容量(PV)是费力的。最近,使用单次大剂量示踪剂的PV测量已得到验证,因此,可以使用大静脉血细胞比容(LVHCT)进行TBV计算。但是,该技术依赖于使用相关因子f细胞比率来调整LVHCT和全身血细胞比容(TBHCT)的差异。正常的f细胞比率为0.9,但从未在失血性休克(HS)康复的患者中进行过研究。这项研究评估HS后不同阶段的f细胞比率,以确定计算TBV的准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号